Ghent University Academic Bibliography

1 – 10 of 23

show: 10
|
sort: year (new to old)

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://biblio.ugent.be/publication?embed=1&q=author%3D%22Klimek%2C+L*%22+or+(type+exact+bookEditor+and+editor%3D%22Klimek%2C+L*%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1&amp;hide_cluster=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

Email this snippet

«previous
1
2
3
next»

2015
- A1
- journalArticle
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation
J Bousquet, HJ Schunemann, J Fonseca, B Samolinski, Claus Bachert UGent, GW Canonica, T Casale, AA Cruz, P Demoly and P Hellings, et al. (2015) ALLERGY. 70(11). p.1372-1392 Mark
- A1
- journalArticle
Effectiveness of MP29-02 for the treatment of allergic rhinitis in real-life: results from a noninterventional study
Ludger Klimek, Claus Bachert UGent, Ralph Mösges, Ullrich Munzel, David Price, J Christian Virchow, Ulrich Wahn and Jean Bousquet (2015) ALLERGY AND ASTHMA PROCEEDINGS. 36(1). p.40-47 Mark
- C3
- conference
MP29-02* provides effective relief in real life in patients previously treated with mono- and multiple-therapy: results from Germany
L Klimek, JC Virchow, U Wahn, R Mösges, H-C Kuhl and Claus Bachert UGent (2015) ALLERGY. 70(suppl. 101). p.503-503 Mark
- A1
- journalArticle
Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps
Jean Bousquet, Claus Bachert UGent, Jonathan Bernstein, G Walter Canonica, Warner Carr, Ronald Dahl, Pascal Demoly, Philippe Devillier, Peter Hellings and Wytske Fokkens, et al. (2015) EXPERT OPINION ON PHARMACOTHERAPY. 16(6). p.913-928 Mark
- C3
- conference
MP29-02* provides effective AR symptom control in real life in all patient types regardless of predominant nasal symptom or presence of ocular symptoms: results from Germany
Claus Bachert UGent, R Mösges, JC Virchow, U Wahn, HC Kuhl and L Klimek (2015) ALLERGY. 70(suppl. 101). p.505-505 Mark
2014
- A1
- journalArticle
MP29-02 (Dymista®): eine neue Behandlungsoption für die allergische Rhinitis
L Klimek, Claus Bachert UGent, M Wagenmann, J Ring and O Pfaar (2014) ALLERGOLOGIE. 37(2). p.55-68 Mark
- A2
- journalArticle
Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases
Oliver Pfaar, Claus Bachert UGent, Albrecht Bufe, Roland Buhl, Christof Ebner, Peter Eng, Frank Friedrichs, Thomas Fuchs, Eckard Hamelmann and Doris Hartwig-Bade, et al. (2014) ALLERGO JOURNAL INTERNATIONAL. 23(8). p.282-319 Mark
- C3
- conference
Real-world effectiveness of a new allergic rhinitis therapy (MP29-02)
L Klimek, JC Virchow, U Wahn, R Moesges, U Munzel and Claus Bachert UGent (2014) ALLERGY. 69(suppl. 99). p.322-322 Mark
2012
- A1
- journalArticle
Leitlinie 'Rhinosinusitis' Langfassung: S2-Leitlinie der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- un Hals-Chirurgie
BA Stuck, Claus Bachert UGent, P Federspil, W Hosemann, L Klimek, R Mösges, O Pfaar, C Rudack, H Sitter and M Wagenmann, et al. (2012) HNO. 60(2). p.141-162 Mark
2011
- A1
- journalArticle
Efficacy and safety of mometasone furoate nasal spray in the treatment of chronic rhinosinusitis
R Mösges, Claus Bachert UGent, C Rudack, B Hauswald, L Klimek, J Spaeth, G Rasp, J Vent and K Hörmann (2011) ADVANCES IN THERAPY. 28(3). p.238-249 Mark

«previous
1
2
3
next»

your query:: Remove author="Klimek, L*" or (type exact bookEditor and editor="Klimek, L*")